Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩8,780 (-0.23%) as of
Key statistics
- Market cap
- 81.27B
- Dividend yield
- 2.27%
- 52-week range
- 0.00 – 10,350.00
- Beta
- 0.47
- Revenue (TTM)
- 39.19B
- Profit margin
- 9.31%
About Choong Ang Vaccine Laboratory Co., Ltd.
Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Daejeon, South Korea
- Employees
- 167
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.